S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.00 (+0.86%)
AAPL   180.75 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.74 (+5.71%)
AMD   192.53 (+9.06%)
BABA   74.02 (-0.76%)
T   16.93 (-0.18%)
F   12.43 (+1.06%)
MU   90.61 (+1.00%)
CGC   3.29 (-2.08%)
GE   156.83 (+0.78%)
DIS   111.51 (+0.64%)
AMC   4.34 (-13.21%)
PFE   26.55 (-1.81%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
NASDAQ:AVAH

Aveanna Healthcare (AVAH) Stock Price, News & Analysis

$2.37
0.00 (0.00%)
(As of 02/29/2024 ET)
Today's Range
$2.33
$2.41
50-Day Range
$2.20
$2.99
52-Week Range
$0.85
$3.00
Volume
82,377 shs
Average Volume
87,287 shs
Market Capitalization
$452.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.78

Aveanna Healthcare MarketRank™ Stock Analysis

Analyst Rating
Strong Sell
1.40 Rating Score
Upside/​Downside
25.5% Downside
$1.78 Price Target
Short Interest
Bearish
2.35% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.19) to ($0.14) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.18 out of 5 stars

Medical Sector

954th out of 958 stocks

Home Health Care Services Industry

7th out of 7 stocks


AVAH stock logo

About Aveanna Healthcare Stock (NASDAQ:AVAH)

Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.

AVAH Stock Price History

AVAH Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
Aveanna Healthcare Promotes Matt Buckhalter To CFO
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
RBC Capital Keeps Their Hold Rating on Aveanna Healthcare Holdings (AVAH)
Aveanna Healthcare Holdings Inc AVAH
Q3 2023 Aveanna Healthcare Holdings Inc Earnings Call
Aveanna Healthcare earnings preview: what Wall Street is expecting
Health Care Quality
See More Headlines
Receive AVAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/10/2023
Today
2/29/2024
Next Earnings (Confirmed)
3/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Home health care services
Sub-Industry
N/A
Current Symbol
NASDAQ:AVAH
Fax
N/A
Employees
3,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$1.78
High Stock Price Target
$3.00
Low Stock Price Target
$1.00
Potential Upside/Downside
-25.5%
Consensus Rating
Strong Sell
Rating Score (0-4)
1.40
Research Coverage
5 Analysts

Profitability

Net Income
$-662,030,000.00
Pretax Margin
-18.56%

Debt

Sales & Book Value

Annual Sales
$1.87 billion
Cash Flow
$3.73 per share
Book Value
($0.03) per share

Miscellaneous

Free Float
177,572,000
Market Cap
$455.85 million
Optionable
Optionable
Beta
2.05
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Rodney D. Windley (Age 76)
    Executive Chairman
    Comp: $2.28M
  • Mr. Jeffrey S. Shaner (Age 51)
    CEO & Director
    Comp: $551.42k
  • Mr. Shannon L. Drake (Age 48)
    Chief Legal Officer & Secretary
    Comp: $401.32k
  • Mr. Matthew Buckhalter
    CFO & Principal Financial Officer
  • Ms. Debbie Stewart
    Senior VP & Principal Accounting Officer
  • Mr. Ed Reisz (Age 65)
    Chief Administrative Officer
  • Mr. Patrick A. Cunningham (Age 68)
    Chief Compliance Officer
  • Ms. Korey Hinz
    President of Medical Solutions
  • Ms. Kristy Rohwedder
    President of Private Duty Nursing
  • Mr. Shane Brinkerhoff
    President of Home Health & Hospice














AVAH Stock Analysis - Frequently Asked Questions

Should I buy or sell Aveanna Healthcare stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aveanna Healthcare in the last year. There are currently 3 sell ratings and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "strong sell" AVAH shares.
View AVAH analyst ratings
or view top-rated stocks.

What is Aveanna Healthcare's stock price target for 2024?

5 brokers have issued 1 year target prices for Aveanna Healthcare's shares. Their AVAH share price targets range from $1.00 to $3.00. On average, they anticipate the company's stock price to reach $1.78 in the next twelve months. This suggests that the stock has a possible downside of 25.5%.
View analysts price targets for AVAH
or view top-rated stocks among Wall Street analysts.

How have AVAH shares performed in 2024?

Aveanna Healthcare's stock was trading at $2.68 on January 1st, 2024. Since then, AVAH shares have decreased by 10.8% and is now trading at $2.39.
View the best growth stocks for 2024 here
.

When is Aveanna Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 14th 2024.
View our AVAH earnings forecast
.

How can I listen to Aveanna Healthcare's earnings call?

Aveanna Healthcare will be holding an earnings conference call on Thursday, March 14th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13743056".

How were Aveanna Healthcare's earnings last quarter?

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) posted its quarterly earnings results on Thursday, August, 10th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.02. The company earned $471.95 million during the quarter, compared to analysts' expectations of $453.19 million. Aveanna Healthcare had a negative trailing twelve-month return on equity of 70.08% and a negative net margin of 18.56%. During the same quarter in the prior year, the firm earned $0.03 earnings per share.

When did Aveanna Healthcare IPO?

(AVAH) raised $478 million in an initial public offering on Thursday, April 29th 2021. The company issued 38,200,000 shares at $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse acted as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

Who are Aveanna Healthcare's major shareholders?

Aveanna Healthcare's stock is owned by many different retail and institutional investors. Top institutional shareholders include Nut Tree Capital Management LP (6.49%), King Street Capital Management L.P. (3.36%), Vanguard Group Inc. (1.32%), Putnam Investments LLC (0.53%), Northern Trust Corp (0.22%) and Nuveen Asset Management LLC (0.13%). Insiders that own company stock include David Afshar, Jeff Shaner, Patrick A Cunningham, Steven E Rodgers, Tony Strange and Victor F Ganzi.
View institutional ownership trends
.

How do I buy shares of Aveanna Healthcare?

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:AVAH) was last updated on 2/29/2024 by MarketBeat.com Staff